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Abstract Aerosomal exocytosis triggered with A23187/Ca 2+ 
was enhanced by rab3AL, a synthetic peptide corresponding to 
the effector domain of the small GTP-binding protein rab3. 
Exocytosis was further enhanced when spermatozoa were also 
exposed to dihutyryl-cAMP, but was prevented when H-89, a 
protein kinase A (PKA) inhibitor, was included. The action of 
rab3AL was not on, or upstream of, phospholipase A2 (PLA2). 
Inhibition of exocytosis by the PLA2 inhibitor aristolochic acid 
was overcome by rab3AL when it was included together with 
lysophosphatidylcholine; this effect was prevented by H-89. 
These results suggest a functional coupling between rab3 protein, 
metabolites generated by PLA2, and cAMP-activated PKA, in 
the final steps leading to membrane fusion during acrosomal 
exocytosis. 
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that regulate docking and fusion of secretory granules with 
the plasma membrane [16-19]. 
Synthetic peptides corresponding to a putative ffector do- 
main of rab3 proteins have been shown to stimulate xocyto- 
sis in permeabilized [20 23] and intact cells [24], and mem- 
brane fusion in a cell-free assay system [25]. We have therefore 
used a sperm model system, where cells are stimulated to 
undergo exocytosis with A23187/Ca 2+, to explore whether 
rab3 might be involved in the final steps of membrane fusion 
during acrosomal exocytosis. We present, for the first time, 
evidence suggesting that rab3 protein, together with PLA2- 
derived metabolites and the cAMP/PKA signalling pathway, 
play an important role during the final steps of acrosomal 
exocytosis in mammalian spermatozoa. 
2. Materials and methods 
1. Introduction 
Mammalian spermatozoa undergo exocytosis of the acroso- 
mal granule (the 'acrosome reaction') in response to oocyte- 
derived stimuli [1-3]; exocytosis can also take place after 
treatment with the ionophore A23187 and Ca 2+ [4,5]. Treat- 
ment with these agonists, including A23187/Ca 2+, results in a 
rapid generation of diacylglycerol (DAG) due to the hydro- 
lysis of polyphosphoinositides by phosphoinositidase C [3,6-8] 
and hydrolysis of phosphatidylcholine by a specific phospho- 
lipase C [3,8,9]. No evidence for the participation of the phos- 
pholipase D/phosphatidic acid phosphohydrolase pathway in 
the generation of DAG has been found [3]. DAG has an 
important role during exocytosis because it activates phospho- 
lipase A2 (PLA2) [10] which, in turn, generates fatty acids and 
lysophospholipids important for membrane fusion [11,12]. 
There is little information on the mechanisms actually in- 
volved in membrane fusion during acrosomal exocytosis. Re- 
cent work [13] has shown that cAMP and protein kinase A 
(PKA) may act downstream of Ca 2+ entry, modulating the 
late steps of exocytosis. However, little attention has been 
paid to other molecular systems involved in the final steps 
of exocytosis in other cell systems [14], such as the ras-like 
small GTP-binding proteins rab3 [15], and related molecules, 
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2.1. Materials 
[1-a4c]Arachidonic acid (toluene solution; spec. act. 54-56 mCi/ 
mmol) was obtained from Amersham International (Amersham, 
Bucks., UK). The ionophore A23187 was purchased from Calbiochem 
(Nottingham, UK). Poly(vinyl)alcohol (type II) and polyvinylpyrroli- 
done were from Sigma (Poole, Dorset, UK). HEPES was from BDH 
(Poole, Dorset, UK). Organic solvents were from BDH or Fisons 
(Loughborough, Leics., UK). The following lipids were purchased 
from Sigma: 1,2-dioleoyl-sn-glycerol, 1,3-dioleoylglycerol, arachidonic 
acid, and lysophosphatidylcholine ( ysoPC) (article L 4129). The PKA 
inhibitor H-89 was from Biomol (Affiniti Research Products, Notting- 
ham, UK). Aristolochic acid was purchased from Aldrich (Milwau- 
kee, MI, USA) or Sigma. All other chemicals were of reagent grade 
and were purchased from BDH or Sigma. The rab3AL peptide was 
kindly donated by Dr. G.J. Law (The Babraham Institute). 
2.2. Preparation, labelling and treatment of spermatozoa 
Throughout the experiments the standard saline incubation medium 
used consisted of 142 mM NaCI, 2.5 mM KOH, 10 mM glucose and 
20 mM HEPES, adjusted to pH 7.55 at 20°C with NaOH [6]; a 
medium containing 222 mM sucrose in place of the NaC1 was used 
for washing spermatozoa. Both media lso contained 1mg poly(vinyl) 
alcohol/ml and 1 mg polyvinylpyrrolidone/ml, andhad an osmolality 
of 305 mOsm/kg. 
Ejaculated ram spermatozoa were separated from seminal plasma 
by dilution and washing through sucrose medium (400×gm~ for 5 
min, and 1000×gm~x for 10 min), as described [26]. 
Labelling was routinely carried out by incubating washed sperma- 
tozoa (about 1 × 108/ml) in 5-10 ml of saline medium containing 0.5 
ktCi [14C]arachidonic acid/ml [11] for 60 min at 37°C. Before stimula- 
tion, spermatozoa were washed through sucrose medium (400 × gm~ 
for 5 min, and 1000×gm~, for 10 min) and resuspended in the saline 
medium containing 3mM Ca 2+. 
Exocytosis of the sperm acrosome was induced by treating cells 
with Ca 2+ (3 mM) and the divalent cation ionophore A23187 (1 
~tM) in saline medium at 37°C, and was monitored by phase-contrast 
microscopy of glutaraldehyde-fixed samples [4]. 
Abbreviations: DAG, diacylglycerol; db-cAMP, dibutyryl-cAMP; 
PKA, protein kinase A; lysoPC, lysophosphatidylcholine; PLA2, 
phospholipase A2
2.3. Lipid analyses 
Reactions were stopped by the addition of chloroform/methanol 
(1:2, v/v) and lipids were then extracted according to Bligh and 
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Dyer [27]. Lipids were separated by thin-layer chromatography on
silica gel 60-coated glass plates (0.25 mm thickness) (E. Merck, Darm- 
stadt, Germany). Neutral lipids were separated by developing the 
plates twice using as solvent n-hexane/diethyl ether/acetic acid 
(70:30:1, v/v). Lipids were visualized by staining in an iodine tank, 
identified by comparison with arachidonic acid, 1,2-dioleoyl-sn-glycer- 
ol and 1,3-dioleoylglycerol standards run on the same plate, scraped 
off, and the radioactivity in each determined by liquid scintillation 
counting 
2.4. Statistics 
Results are means + S.E.M. Significance of results was examined 
after data transformation (arcsin ~/(x + 100) for percentages of exocy- 
tosis, and logx0 for other variables), using Student's t-test or analysis 
of variance (ANOVA). Values of P< 0.05 were regarded as statisti- 
cally significant. 
3.  Resu l t s  
Treatment of ram spermatozoa with A23187 (1 gM) and 
Ca 2+ (3 raM) resulted in a time-dependent i crease in the 
number of cells undergoing acrosomal exocytosis (Fig. 1); 
maximal percentages of exocytosis (,-~90%) were seen 30 
min after the beginning of treatment (not shown). Exocytosis 
did not take place when cells were not exposed to A23187 
(Fig. 1A,B) or were treated with A23187 in the absence of 
Ca 2+ (not shown). 
We tested on exocytosis triggered with A23187/Ca 2+ the 
effect of rab3AL peptide (VSALGIDFKVKTIYRN), a two- 
amino-acid substituted erivative of the effector domain of 
rab3 (VSTVGIDFKVKTIYRN), which was previously found 
to be more potent han the authentic peptide [21,22,24]. Ad- 
dition of 25 or 50 gM rab3AL, together with A23187/Ca 2+, 
caused a slight reduction in the number of cells undergoing 
exocytosis (Fig. 1A). At 100 gM, rab3AL inhibited exocytosis 
at 5 and 10 min (2-factor ANOVA, treatment: P<0.001; 
time: P < 0.0001), but it was stimulatory at 15 min (Student's 
t-test, P=0.003). Exposure of sperm cells to rab3AL alone 
(100 laM), in the presence of Ca 2+, did not affect cell integrity 
(i.e. did not result in exocytosis) (Fig. 1A,B) and did not alter 
sperm viability, as revealed by a lack of change in sperm 
motility (not shown). On the other hand, when rab3AL was 
added 2.5 min after spermatozoa were stimulated with 
A23187, there was a concentration-dependent increase in the 
number or cells undergoing exocytosis (2-factor ANOVA, 
treament: P < 0.007; time: P < 0.0001) (Fig. 1B). The concen- 
trations of rab3AL enhancing exocytosis in spermatozoa are 
similar to those found to stimulate xocytosis in other cells 
[21,22,24]. It is not entirely clear why rab3AL showed a slight 
inhibitory activity when added at 0 min, and a stimulatory 
effect when added at 2.5 min. One simple explanation is that 
the ionophore A23187 may bind to rab3AL when they are 
mixed together before addition of sperm suspension; this 
would decrease its activity, as seen when bovine serum albu- 
min is a component of incubation media. This would not take 
place if rab3AL is added once spermatozoa h ve been exposed 
to the ionophore. Another possibility is that, after A23187 
treatment, sperm membranes become more permeable to the 
rab3-peptide allowing its entry into the cells. 
To investigate if the stimulatory effect of rab3AL is related 
to the activation of pathways underlying exocytosis in sper- 
matozoa, we examined generation of arachidonic acid as an 
indicator of PLA2 activation [11]. Ram spermatozoa were 
labelled with [14C]arachidonic acid, washed, resuspended in
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Fig. 1. Effect of rab3AL on A23187/Ca2+-induced acrosomal exocy- 
tosis. Ram spermatozoa in saline medium with 3 mM Ca 2+ were 
stimulated with A23187 (1 I.tM) for various times in the absence or 
presence of rab3AL. Sperm sub-samples were fixed with a glutaral- 
dehyde fixative and examined by phase contrast microscopy. (A) ra- 
b3AL added at 0 min, together with A23187 (n=3). (B) rab3AL 
added 2.5 min after A23187 (n=3). (m) Control (Ca 2+ alone); (O) 
A23187/Ca2+; (e) A23187/Ca 2+ plus rab3AL 25 gM; ([]) A23187/ 
Ca 2+ plus rab3AL 50 gM; (11) A23187/Ca 2+ plus rab3AL 100 I.tM, 
(x) rab3AL 100 alone p.M. 
saline medium and stimulated with A23187/Ca 2+ in the ab- 
scence or presence of rab3AL. Stimulation with A23187/Ca 2+ 
resulted in a considerable increase in arachidonic acid release. 
When cells were stimulated with A23187/Ca 2+, and rab3AL 
(100 gM) was included 2.5 min after the beginning of treat- 
ment, the rise in arachidonic acid was not different from that 
seen with A23187/Ca 2+ alone (Table 1). Since PLA2 is stimu- 
lated by messengers generated by upstream events, such as the 
DAG formed by phosphoinositidase C and phospholipase C 
actions [10], these results also suggest hat rab3AL does not 
affect events upstream of PLA2. 
To test whether the effect of rab3AL on sperm acrosomal 
exocytosis i related to the activation of the cAMP/PKA mes- 
senger system, we first examined whether dibutyryl-cAMP 
(db-cAMP) modulated the effect of rab3AL. Fig. 2 shows 
that when spermatozoa were stimulated with A23187/Ca z+, 
inclusion of db-cAMP (1 mM) resulted in an enhancement 
of exocytosis, similar to that observed with inclusion of ra- 
b3AL; the exposure of sperm cells to db-cAMP alone, in the 
J. Garde, E.R.S. Roldan/FEBS Letters 391 (1996) 263-268 265 
presence of Ca 2+, did not affect cell motility or integrity (data 
not shown). When spermatozoa stimulated with A23187/Ca 2+ 
were exposed to both db-cAMP and rab3AL, the levels of 
exocytosis were higher (Student's t-test, P< 0.01) than those 
seen when either db-cAMP or rab3AL were added (Fig. 2), 
suggesting a coupling of processes activated by the cAMP/ 
PKA and rab3 systems (see below). 
To obtain additional evidence for the involvement of the 
cAMP/PKA system, we then examined the effects of H-89, a 
PKA specific inhibitor [28] (Fig. 3). When spermatozoa were 
treated with A23187/Ca 2+ and H-89 (0.3 ktM), there was a 
reduction in the number of cells undergoing exocytosis in 
relation to the response seen with A23187/Ca 2+ alone. 
Furthermore, the stimulatory effect of rab3AL was clearly 
reduced by H-89. The effect of H-89 was not on the viability 
of cells, because xposure to H-89 alone did not alter sperm 
motility or integrity (data not shown). It could be argued that, 
although H-89 inhibited the stimulatory effect of rab3AL, 
these results do not allow for a clear distinction between the 
inhibition exerted by H-89 on exocytosis stimulated by 
A23187 and the inhibition of rab3AL-stimulated xocytosis. 
We have, therefore, carried out an additional series of experi- 
ments concentrating on events downstream of PLA2. 
Recent work [13] has suggested that, in the final steps of 
membrane fusion, the cAMP/PKA messenger system could 
modulate vents downstream of PLA2, acting together with 
metabolites generated by PLA2 and, perhaps, proteins of the 
rab3/rabphilin system. We have therefore tested whether ly- 
soPC, a metabolite generated by PLA2, affects the ability of 
rab3AL to enhance exocytosis. To concentrate on events 
downstream of PLA2, spermatozoa were treated with the 
PLA2 inhibitor aristolochic acid [29,30], a reagent found to 
inhibit acrosomal exocytosis [13]; test reagents were then in- 
cluded to examine whether they would restore exocytosis. 
Spermatozoa treated with A23187/Ca z+ in the presence of 
aristolochic acid (400 /aM) did not undergo exocytosis (Fig. 
4A); aristolochic acid by itself affected neither cell integrity 
nor motility (data not shown). When spermatozoa were treat- 
ed with A23187/Ca 2+ and aristolochic acid, inclusion of ra- 
b3AL (100 pM) did not restore the ability of sperm cells to 
undergo exocytosis. However, when spermatozoa were ex- 
posed to a sub-optimal concentration of lysoPC (2.5 /ag/ml) 
[11] plus rab3AL, spermatozoa did respond, with a higher 
proportion of cells undergoing exocytosis than that seen 
when only lysoPC was included (2-factor ANOVA, treatment: 
P < 0.0001; time: P < 0.0001) (Fig. 4A). Previous work has 
Table 1 
Effect of rab3AL on the A23187/Ca~+-induced release of arachido- 
nic acid 
Treatments [x4C]Arachidonic a id after 5 min 
(cpm/10 s spermatozoa) 
Control (Ca 2+ alone) 378 + 22 
A23187/Ca 2+ 1392 + 97 ~ 
A23187/Ca 2+ +rab3AL 1284 + 36 a 
rab3AL alone 450 +_ 50 
Ram spermatozoa were labelled with 0.5 ~tCi of [14C]arachidonic acid/ 
ml for 60 min at 37°C, washed, resuspended in saline medium with 
Ca 2+ (3 mM), treated with A23187 (1 ~tM) and, 2.5 min later, rab3AL 
(100 ~tM) or its solvent as control. After 5 min, lipids were extracted, 
separated and quantified. Results are means +_ S.E.M. of duplicate 
assays carried out on two occasions. 
~When compared with control: P< 0.01. 
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Fig. 2. Effect of db-cAMP and rab3AL on A23187/Ca2+-induced ac- 
rosomal exocytosis. Ram spermatozoa in saline medium with 3 mM 
Ca 2+ were stimulated with A23187 (1 gM) for various times in the 
absence or presence of db-cAMP (1 mM) or rab3AL (100 ktM); ra- 
b3AL was added 2.5 min after A23187. Sperm samples were fixed 
with a glutaraldehyde fixative and examined by phase contrast mi- 
croscopy (n= 3). a, different from control, P<0.001; b, different 
from A23187/Ca 2+, P< 0.001; c, different from A23187/Ca 2+ plus 
db-cAMP or rab3AL, P < 0.01. 
shown that this sub-optimal concentration f lysoPC contrib- 
uted to restoring exocytosis when spermatozoa exposed to 
A23187 and aristolochic acid were treated with db-cAMP 
[13]. Therefore, we examined whether the effect of lysoPC 
plus rab3AL described above was coupled to the cAMP/ 
PKA system by including the PKA inhibitor H-89. As seen 
in Fig. 4B, inclusion of H-89 reduced the occurrence of exo- 
cytosis stimulated with rab3AL and lysoPC, thus strengthen- 
ing the idea that the rab3 protein system is functionally 
coupled to the cAMP/PKA signalling system. Exposure of 
cells to all reagents in the absence of A23187 revealed that 
no acrosome loss took place and, hence, that cell integrity was 
not affected (Fig. 4B); under these conditions, cell motility 
was also not altered (data not shown). 
4. Discussion 
The results of this study suggest hat rab3 protein has an 
important role in the sequence nding in membrane fusion 
during exocytosis of the sperm acrosome. The rab3 protein 
appears to be functionally coupled to both the cAMP/PKA 
messenger system and to metabolites generated by PLA2. 
In regulated secretory cells, rab3 proteins are leading can- 
didates for the control of exocytosis. [16]. Among over 30 rab 
proteins, rab3 represents a small subfamily (rab3a, rab3b, 
rab3c, rab3d) expressed in a variety of cells: rab3a mainly 
in neurons and chromaffin cells; rab3b in pituitary cells, pla- 
telets, and mast cells; rab3c in neurons; and rab3d in adipo- 
cytes and mast cells [16,19,31]. It has been postulated that 
rab3 exercises a positive regulatory role in exocytosis because 
rab3AL, a synthetic peptide corresponding to the rab3 effector 
domain, stimulates secretion in a variety of cells [20-24]. Our 
results agree with this idea, because xposure of spermatozoa 
to rab3AL enhanced exocytosis stimulated with A23187/Ca 2+. 
However, since the putative ffector domains of the different 
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rab3 isoforms are very similar (cf. [31,32]), the response to 
rab3AL does not allow us to implicate a specific member of 
the rab3 subfamily (cf. [31]). 
It has been argued that some rab proteins do not necessa- 
rily act as positive regulators of membrane fusion because 
overexpression of wild type rab3a actually led to inhibition 
of exocytosis in chromaffin cells [33]. Thus, some rab3 iso- 
forms may prevent exocytosis (i.e. act as negative regulators) 
until a signal is received and inhibition is relieved [19]; this 
has led to the separation of rab proteins into inhibitory rab 
proteins (I-rab) (e.g. rab3a) and facilitatory rab proteins (F- 
rab) (e.g. rab3b and rab3d) [18,34,35]. Nevertheless, an expla- 
nation of how rab3AL would affect rab3a intracellular func- 
tion and cause stimulation of exocytosis has been offered [23]. 
It has also been argued that some of the effects seen with 
the synthetic peptide rab3AL may be related to actions on 
other cell processes (e.g. formation of inositol 1,4,5-tris- 
phosphate [36]), or to the net positive charge of the peptide 
[37]. Our results, however, are most likely due to a stimulation 
of the final steps of fusion, rather than to alternative actions. 
Moreover, the results we obtained were also highly specific; 
i.e. not related to a simple perturbation of membranes. These 
conclusions are based on two sets of evidence. Firstly, it was 
observed that rab3AL was not able to influence PLA2 activity. 
This indicates that the peptide acts neither on this enzyme nor 
on upstream events that regulate PLAz function [10]; if ra- 
b3AL were modulating events upstream of PLA2, changes in 
the activity of the enzyme would have been observed. Further- 
more, rab3AL helped to restore exocytosis in spermatozoa 
treated with a PLAz inhibitor. Secondly, responses to rab3AL 
were seen only under specific onditions and they were inhib- 
ited or enhanced by modulators of other messengers systems. 
Interestingly, we found that rab3AL could stimulate non-per- 
meabilized sperm cells, in agreement with results found in 
other cell types [24], and the finding that exocytosis in non- 
permeabilized mouse spermatozoa could be triggered by either 
mastoparan or GTPTS [38,39]. 
The question that arises is how would tab3 associate with 
secretory granule membranes and regulate fusion, and how is 
it functionally coupled to other messenger systems? It is now 
clear that rab3 interacts with a series of proteins. Among 
them, rabphilin3A, originally described as a synaptic vesicle 
protein and recently identified in hormone secreting cells from 
various species [40], has been found to interact with rab3a and 
rab3c in a GTP-dependent manner [41,42]. The widely ex- 
pressed protein rabin3 interacts with rab3a and rab3d (but 
not with rab3c) [43], whereas SNAP-25, VAMP/synaptobre- 
vin-2, and syntaxins have been found to exist as a complex 
with rab3a in brain presynaptic terminals [44]. In addition, 
rab3a may also interact with SNARE [44,45] or the cytosolic 
protein doublet REEP-1 and -2 [23]. The mode of interaction 
with most of these target proteins is still unclear and it is not 
well known, as indicated above, if inhibitory or facilitatory 
'complexes' are formed with tab3. For example, both inhibi- 
tory [19] and facilitatory [17] models have been presented to 
explain how rab3a-GTP may associate with target proteins on 
granule membranes, how they interact with putative 'docking' 
proteins in the plasma membrane, and how rab3a would dis- 
sociate from the complex before [19] or after [15,17,46] fusion. 
The fusion process may also be regulated by the cAMP/ 
PKA signalling system. Recently, it has been found that 
some rab3 target proteins are phosphorylated by cAMP-de- 
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Fig. 3. Effect of rab3AL and H-89 on A23187/Ca2+-induced acroso- 
real exocytosis. Ram spermatozoa in saline medium with 3 mM 
Ca 2+ were incubated in the absence or presence of H-89 (0.3 ~tM) 
for 5 min, then stimulated, or not, with A23187 (1 pM), and after 
2.5 min exposed to rab3AL (100 ~tM). Sperm samples were fixed 
with a glutaraldehyde fixative and examined by phase contrast mi- 
croscopy (n=3). a, different from control, P<0.001; b, different 
from A23187/Ca 2+, P<0.001; c, different from A23187/Ca 2+ plus 
rab3AL, P < 0.001. 
pendent PKA [47,48], with rab3a not serving as a substrate 
for this kinase. Thus, our results showing that db-cAMP or 
H-89 stimulates or inhibits, respectively, the occurrence of 
exocytosis support he idea [13] that the cAMP/PKA messen- 
ger system could modulate membrane fusion in spermatozoa. 
Our results also indicate that rab3 action in spermatozoa 
could be coupled to the cAMP/PKA messenger system be- 
cause (a) the stimulatory effect of rab3AL was further en- 
hanced by db-cAMP, (b) the effect of rab3AL was reduced 
by the PKA inhibitor H-89, and (c) in sperm cells where PLA2 
was inhibited with aristolochic acid, the stimulatory effect of 
rab3AL was, again, reduced by H-89. It is important o em- 
phasise that although the cAMP/PKA system may be impor- 
tant in the modulation of the final steps of fusion, some fu- 
sion-related events may not be controlled by this signalling 
system. This is suggested by the finding that H-89 did not 
cause a complete inhibition of exocytosis triggered by 
A23187/Ca 2+, or that enhanced by rab3AL. It is thus likely 
that some protein(s) involved in the late steps of fusion may 
be regulated by other protein kinases (e.g. rabphilin3A is also 
phosphorylated by Ca2+/calmodulin-dependent protein kinase 
II [48,49]), or that some of these proteins may not be regu- 
lated by phosphorylation. 
Previous work has shown that metabolites generated by 
PLA2 are important for membrane fusion during acrosomal 
exocytosis [11]. The present study has revealed that PLA2- 
derived metabolites are functionally coupled to rab3 action: 
in sperm cells where PLA2 was inhibited by aristolochic acid, 
the inclusion of lysoPC plus rab3AL caused higher levels of 
exocytosis than each of the compounds added alone. Thus, 
perturbation of membrane phospholipids by release of lysoPC 
may facilitate the action of the rab3 fusion complex. Finally, 
indication that the cAMP/PKA messenger system may be 
coupled both to PLA2-derived metabolites and to rab3 comes 
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Fig. 4. Effect of aristolochic acid, rab3AL, lysoPC and/or H-89 on 
A23187/Ca2+-induced acrosomal exocytosis. Ram spermatozoa in 
saline medium with 3 mM Ca 2+ were exposed to aristolochic acid 
(400 p.M), lysoPC (2.5 ktg/ml), H-89 (0.3 laM), or solvent (as con- 
trol) for 5 min, then exposed to A23187 (1 IxM); rab3AL (100 p.M) 
was then added, 2.5 min after A23187. Sperm sub-samples were 
fixed with a glutaraldehyde fixative and examined by phase contrast 
microscopy. (A) rab3AL and lysoPC overcome the inhibitory effect 
of aristolochic acid (n=3). ([]) Control (Ca 2+ alone); (O) A23187/ 
Ca2+; (O) A23187/Ca 2+ plus aristolochic acid; ([]) A23187/Ca 2+ 
plus aristolochic acid and rab3AL; (11) A23187/Ca 2+ plus aristo- 
lochic acid and lysoPC; (A) A23187/Ca ~+ plus aristolochic acid, ly- 
soPC and rab3AL. (B) H-89 reduces the rab3AL/lysoPC-induced 
stimulation of exocytosis (n = 3). a, different from control, 
P<0.001; b, different from A23187/Ca 2+, P<0.005; c, different 
from A23187/Ca 2+ plus aristolochic acid, P< 0.01; d, different from 
A23187/Ca 2+ plus aristolochic acid and lysoPC, P<0.02, e, differ- 
ent from A23187/Ca 2+ plus aristolochic acid, rab3AL and lysoPC, 
P < 0.005. 
from the finding that H-89 reversed the stimulation seen with 
rab3AL plus lysoPC. 
In conclusion, our results suggest hat a rab3 fusion com- 
plex and the cAMP/PKA messenger system, in conjunction 
with PLA2-derived metabolites such as lysoPC, may modulate 
the final steps of fusion during exocytosis of the sperm acro- 
some. 
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